 | • レポートコード：MRC2-11QY03243 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、151ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は生物製剤・バイオシミラーのグローバル市場について調査・分析したレポートです。種類別（抗生物質、酵素、ホルモン、非特許生物学的試薬、その他）市場規模、用途別（腫瘍、糖尿病、心血管、血友病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別生物製剤・バイオシミラーの競争状況、市場シェア ・世界の生物製剤・バイオシミラー市場：種類別市場規模 2015年-2020年（抗生物質、酵素、ホルモン、非特許生物学的試薬、その他） ・世界の生物製剤・バイオシミラー市場：種類別市場規模予測 2021年-2026年（抗生物質、酵素、ホルモン、非特許生物学的試薬、その他） ・世界の生物製剤・バイオシミラー市場：用途別市場規模 2015年-2020年（腫瘍、糖尿病、心血管、血友病、その他） ・世界の生物製剤・バイオシミラー市場：用途別市場規模予測 2021年-2026年（腫瘍、糖尿病、心血管、血友病、その他） ・北米の生物製剤・バイオシミラー市場分析：米国、カナダ ・ヨーロッパの生物製剤・バイオシミラー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの生物製剤・バイオシミラー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の生物製剤・バイオシミラー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの生物製剤・バイオシミラー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：fizer、Roche、Amgen、AbbVie、Sanofi、Johnson & Johnson、Novo Nordisk、Novartis、Merck、Lilly、3sbio、Changchun High Tech、CP Guojian Pharmacy、Biotech Pharma、Gelgen Biopharma、Sandoz、Teva、Hospira、Mylan ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Biologics & Biosimilars Market
The global Biologics & Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Biologics & Biosimilars Scope and Market Size
Biologics & Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologics & Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biologics & Biosimilars market is segmented into
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
Segment by Application, the Biologics & Biosimilars market is segmented into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Regional and Country-level Analysis
The Biologics & Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biologics & Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biologics & Biosimilars Market Share Analysis
Biologics & Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biologics & Biosimilars business, the date to enter into the Biologics & Biosimilars market, Biologics & Biosimilars product introduction, recent developments, etc.
The major vendors covered:
fizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
1 Study Coverage
1.1 Biologics & Biosimilars Product Introduction
1.2 Market Segments
1.3 Key Biologics & Biosimilars Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biologics & Biosimilars Market Size Growth Rate by Type
1.4.2 Antibiotic
1.4.3 Enzyme
1.4.4 Hormone
1.4.5 Non-Patented Biological Reagents
1.4.6 Other
1.5 Market by Application
1.5.1 Global Biologics & Biosimilars Market Size Growth Rate by Application
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biologics & Biosimilars Market Size, Estimates and Forecasts
2.1.1 Global Biologics & Biosimilars Revenue 2015-2026
2.1.2 Global Biologics & Biosimilars Sales 2015-2026
2.2 Global Biologics & Biosimilars, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biologics & Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biologics & Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biologics & Biosimilars Competitor Landscape by Players
3.1 Biologics & Biosimilars Sales by Manufacturers
3.1.1 Biologics & Biosimilars Sales by Manufacturers (2015-2020)
3.1.2 Biologics & Biosimilars Sales Market Share by Manufacturers (2015-2020)
3.2 Biologics & Biosimilars Revenue by Manufacturers
3.2.1 Biologics & Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 Biologics & Biosimilars Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biologics & Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biologics & Biosimilars Revenue in 2019
3.2.5 Global Biologics & Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biologics & Biosimilars Price by Manufacturers
3.4 Biologics & Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Biologics & Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologics & Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into Biologics & Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biologics & Biosimilars Market Size by Type (2015-2020)
4.1.1 Global Biologics & Biosimilars Sales by Type (2015-2020)
4.1.2 Global Biologics & Biosimilars Revenue by Type (2015-2020)
4.1.3 Biologics & Biosimilars Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biologics & Biosimilars Market Size Forecast by Type (2021-2026)
4.2.1 Global Biologics & Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global Biologics & Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 Biologics & Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biologics & Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biologics & Biosimilars Market Size by Application (2015-2020)
5.1.1 Global Biologics & Biosimilars Sales by Application (2015-2020)
5.1.2 Global Biologics & Biosimilars Revenue by Application (2015-2020)
5.1.3 Biologics & Biosimilars Price by Application (2015-2020)
5.2 Biologics & Biosimilars Market Size Forecast by Application (2021-2026)
5.2.1 Global Biologics & Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global Biologics & Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global Biologics & Biosimilars Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biologics & Biosimilars by Country
6.1.1 North America Biologics & Biosimilars Sales by Country
6.1.2 North America Biologics & Biosimilars Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biologics & Biosimilars Market Facts & Figures by Type
6.3 North America Biologics & Biosimilars Market Facts & Figures by Application
7 Europe
7.1 Europe Biologics & Biosimilars by Country
7.1.1 Europe Biologics & Biosimilars Sales by Country
7.1.2 Europe Biologics & Biosimilars Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologics & Biosimilars Market Facts & Figures by Type
7.3 Europe Biologics & Biosimilars Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biologics & Biosimilars by Region
8.1.1 Asia Pacific Biologics & Biosimilars Sales by Region
8.1.2 Asia Pacific Biologics & Biosimilars Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biologics & Biosimilars Market Facts & Figures by Type
8.3 Asia Pacific Biologics & Biosimilars Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biologics & Biosimilars by Country
9.1.1 Latin America Biologics & Biosimilars Sales by Country
9.1.2 Latin America Biologics & Biosimilars Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biologics & Biosimilars Market Facts & Figures by Type
9.3 Central & South America Biologics & Biosimilars Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biologics & Biosimilars by Country
10.1.1 Middle East and Africa Biologics & Biosimilars Sales by Country
10.1.2 Middle East and Africa Biologics & Biosimilars Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biologics & Biosimilars Market Facts & Figures by Type
10.3 Middle East and Africa Biologics & Biosimilars Market Facts & Figures by Application
11 Company Profiles
11.1 fizer
11.1.1 fizer Corporation Information
11.1.2 fizer Description and Business Overview
11.1.3 fizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 fizer Biologics & Biosimilars Products Offered
11.1.5 fizer Related Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Description and Business Overview
11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Roche Biologics & Biosimilars Products Offered
11.2.5 Roche Related Developments
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Description and Business Overview
11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen Biologics & Biosimilars Products Offered
11.3.5 Amgen Related Developments
11.4 AbbVie
11.4.1 AbbVie Corporation Information
11.4.2 AbbVie Description and Business Overview
11.4.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AbbVie Biologics & Biosimilars Products Offered
11.4.5 AbbVie Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Biologics & Biosimilars Products Offered
11.5.5 Sanofi Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Biologics & Biosimilars Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Corporation Information
11.7.2 Novo Nordisk Description and Business Overview
11.7.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novo Nordisk Biologics & Biosimilars Products Offered
11.7.5 Novo Nordisk Related Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Description and Business Overview
11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Biologics & Biosimilars Products Offered
11.8.5 Novartis Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Biologics & Biosimilars Products Offered
11.9.5 Merck Related Developments
11.10 Lilly
11.10.1 Lilly Corporation Information
11.10.2 Lilly Description and Business Overview
11.10.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lilly Biologics & Biosimilars Products Offered
11.10.5 Lilly Related Developments
11.1 fizer
11.1.1 fizer Corporation Information
11.1.2 fizer Description and Business Overview
11.1.3 fizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 fizer Biologics & Biosimilars Products Offered
11.1.5 fizer Related Developments
11.12 Changchun High Tech
11.12.1 Changchun High Tech Corporation Information
11.12.2 Changchun High Tech Description and Business Overview
11.12.3 Changchun High Tech Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Changchun High Tech Products Offered
11.12.5 Changchun High Tech Related Developments
11.13 CP Guojian Pharmacy
11.13.1 CP Guojian Pharmacy Corporation Information
11.13.2 CP Guojian Pharmacy Description and Business Overview
11.13.3 CP Guojian Pharmacy Sales, Revenue and Gross Margin (2015-2020)
11.13.4 CP Guojian Pharmacy Products Offered
11.13.5 CP Guojian Pharmacy Related Developments
11.14 Biotech Pharma
11.14.1 Biotech Pharma Corporation Information
11.14.2 Biotech Pharma Description and Business Overview
11.14.3 Biotech Pharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Biotech Pharma Products Offered
11.14.5 Biotech Pharma Related Developments
11.15 Gelgen Biopharma
11.15.1 Gelgen Biopharma Corporation Information
11.15.2 Gelgen Biopharma Description and Business Overview
11.15.3 Gelgen Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Gelgen Biopharma Products Offered
11.15.5 Gelgen Biopharma Related Developments
11.16 Sandoz
11.16.1 Sandoz Corporation Information
11.16.2 Sandoz Description and Business Overview
11.16.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Sandoz Products Offered
11.16.5 Sandoz Related Developments
11.17 Teva
11.17.1 Teva Corporation Information
11.17.2 Teva Description and Business Overview
11.17.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Teva Products Offered
11.17.5 Teva Related Developments
11.18 Hospira
11.18.1 Hospira Corporation Information
11.18.2 Hospira Description and Business Overview
11.18.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Hospira Products Offered
11.18.5 Hospira Related Developments
11.19 Mylan
11.19.1 Mylan Corporation Information
11.19.2 Mylan Description and Business Overview
11.19.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Mylan Products Offered
11.19.5 Mylan Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biologics & Biosimilars Market Estimates and Projections by Region
12.1.1 Global Biologics & Biosimilars Sales Forecast by Regions 2021-2026
12.1.2 Global Biologics & Biosimilars Revenue Forecast by Regions 2021-2026
12.2 North America Biologics & Biosimilars Market Size Forecast (2021-2026)
12.2.1 North America: Biologics & Biosimilars Sales Forecast (2021-2026)
12.2.2 North America: Biologics & Biosimilars Revenue Forecast (2021-2026)
12.2.3 North America: Biologics & Biosimilars Market Size Forecast by Country (2021-2026)
12.3 Europe Biologics & Biosimilars Market Size Forecast (2021-2026)
12.3.1 Europe: Biologics & Biosimilars Sales Forecast (2021-2026)
12.3.2 Europe: Biologics & Biosimilars Revenue Forecast (2021-2026)
12.3.3 Europe: Biologics & Biosimilars Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biologics & Biosimilars Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biologics & Biosimilars Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biologics & Biosimilars Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biologics & Biosimilars Market Size Forecast by Region (2021-2026)
12.5 Latin America Biologics & Biosimilars Market Size Forecast (2021-2026)
12.5.1 Latin America: Biologics & Biosimilars Sales Forecast (2021-2026)
12.5.2 Latin America: Biologics & Biosimilars Revenue Forecast (2021-2026)
12.5.3 Latin America: Biologics & Biosimilars Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biologics & Biosimilars Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biologics & Biosimilars Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biologics & Biosimilars Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biologics & Biosimilars Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biologics & Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologics & Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Biologics & Biosimilars Market Segments
Table 2. Ranking of Global Top Biologics & Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biologics & Biosimilars Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antibiotic
Table 5. Major Manufacturers of Enzyme
Table 6. Major Manufacturers of Hormone
Table 7. Major Manufacturers of Non-Patented Biological Reagents
Table 8. Major Manufacturers of Other
Table 9. Global Biologics & Biosimilars Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Biologics & Biosimilars Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Biologics & Biosimilars Sales by Regions 2015-2020 (K Units)
Table 12. Global Biologics & Biosimilars Sales Market Share by Regions (2015-2020)
Table 13. Global Biologics & Biosimilars Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Biologics & Biosimilars Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Biologics & Biosimilars Sales Share by Manufacturers (2015-2020)
Table 16. Global Biologics & Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Biologics & Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics & Biosimilars as of 2019)
Table 18. Biologics & Biosimilars Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Biologics & Biosimilars Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Biologics & Biosimilars Price (2015-2020) (USD/Unit)
Table 21. Biologics & Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Biologics & Biosimilars Product Type
Table 23. Date of International Manufacturers Enter into Biologics & Biosimilars Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Biologics & Biosimilars Sales by Type (2015-2020) (K Units)
Table 26. Global Biologics & Biosimilars Sales Share by Type (2015-2020)
Table 27. Global Biologics & Biosimilars Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Biologics & Biosimilars Revenue Share by Type (2015-2020)
Table 29. Biologics & Biosimilars Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Biologics & Biosimilars Sales by Application (2015-2020) (K Units)
Table 31. Global Biologics & Biosimilars Sales Share by Application (2015-2020)
Table 32. North America Biologics & Biosimilars Sales by Country (2015-2020) (K Units)
Table 33. North America Biologics & Biosimilars Sales Market Share by Country (2015-2020)
Table 34. North America Biologics & Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Biologics & Biosimilars Revenue Market Share by Country (2015-2020)
Table 36. North America Biologics & Biosimilars Sales by Type (2015-2020) (K Units)
Table 37. North America Biologics & Biosimilars Sales Market Share by Type (2015-2020)
Table 38. North America Biologics & Biosimilars Sales by Application (2015-2020) (K Units)
Table 39. North America Biologics & Biosimilars Sales Market Share by Application (2015-2020)
Table 40. Europe Biologics & Biosimilars Sales by Country (2015-2020) (K Units)
Table 41. Europe Biologics & Biosimilars Sales Market Share by Country (2015-2020)
Table 42. Europe Biologics & Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Biologics & Biosimilars Revenue Market Share by Country (2015-2020)
Table 44. Europe Biologics & Biosimilars Sales by Type (2015-2020) (K Units)
Table 45. Europe Biologics & Biosimilars Sales Market Share by Type (2015-2020)
Table 46. Europe Biologics & Biosimilars Sales by Application (2015-2020) (K Units)
Table 47. Europe Biologics & Biosimilars Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Biologics & Biosimilars Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Biologics & Biosimilars Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Biologics & Biosimilars Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Biologics & Biosimilars Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Biologics & Biosimilars Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Biologics & Biosimilars Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Biologics & Biosimilars Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Biologics & Biosimilars Sales Market Share by Application (2015-2020)
Table 56. Latin America Biologics & Biosimilars Sales by Country (2015-2020) (K Units)
Table 57. Latin America Biologics & Biosimilars Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Biologics & Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Biologics & Biosimilars Revenue Market Share by Country (2015-2020)
Table 60. Latin America Biologics & Biosimilars Sales by Type (2015-2020) (K Units)
Table 61. Latin America Biologics & Biosimilars Sales Market Share by Type (2015-2020)
Table 62. Latin America Biologics & Biosimilars Sales by Application (2015-2020) (K Units)
Table 63. Latin America Biologics & Biosimilars Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Biologics & Biosimilars Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Biologics & Biosimilars Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Biologics & Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Biologics & Biosimilars Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Biologics & Biosimilars Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Biologics & Biosimilars Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Biologics & Biosimilars Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Biologics & Biosimilars Sales Market Share by Application (2015-2020)
Table 72. fizer Corporation Information
Table 73. fizer Description and Major Businesses
Table 74. fizer Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. fizer Product
Table 76. fizer Recent Development
Table 77. Roche Corporation Information
Table 78. Roche Description and Major Businesses
Table 79. Roche Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Roche Product
Table 81. Roche Recent Development
Table 82. Amgen Corporation Information
Table 83. Amgen Description and Major Businesses
Table 84. Amgen Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Amgen Product
Table 86. Amgen Recent Development
Table 87. AbbVie Corporation Information
Table 88. AbbVie Description and Major Businesses
Table 89. AbbVie Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. AbbVie Product
Table 91. AbbVie Recent Development
Table 92. Sanofi Corporation Information
Table 93. Sanofi Description and Major Businesses
Table 94. Sanofi Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Sanofi Product
Table 96. Sanofi Recent Development
Table 97. Johnson & Johnson Corporation Information
Table 98. Johnson & Johnson Description and Major Businesses
Table 99. Johnson & Johnson Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Johnson & Johnson Product
Table 101. Johnson & Johnson Recent Development
Table 102. Novo Nordisk Corporation Information
Table 103. Novo Nordisk Description and Major Businesses
Table 104. Novo Nordisk Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Novo Nordisk Product
Table 106. Novo Nordisk Recent Development
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Novartis Product
Table 111. Novartis Recent Development
Table 112. Merck Corporation Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Merck Product
Table 116. Merck Recent Development
Table 117. Lilly Corporation Information
Table 118. Lilly Description and Major Businesses
Table 119. Lilly Biologics & Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Lilly Product
Table 121. Lilly Recent Development
Table 122. 3sbio Corporation Information
Table 123. 3sbio Description and Major Businesses
Table 124. 3sbio Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. 3sbio Product
Table 126. 3sbio Recent Development
Table 127. Changchun High Tech Corporation Information
Table 128. Changchun High Tech Description and Major Businesses
Table 129. Changchun High Tech Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Changchun High Tech Product
Table 131. Changchun High Tech Recent Development
Table 132. CP Guojian Pharmacy Corporation Information
Table 133. CP Guojian Pharmacy Description and Major Businesses
Table 134. CP Guojian Pharmacy Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. CP Guojian Pharmacy Product
Table 136. CP Guojian Pharmacy Recent Development
Table 137. Biotech Pharma Corporation Information
Table 138. Biotech Pharma Description and Major Businesses
Table 139. Biotech Pharma Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. Biotech Pharma Product
Table 141. Biotech Pharma Recent Development
Table 142. Gelgen Biopharma Corporation Information
Table 143. Gelgen Biopharma Description and Major Businesses
Table 144. Gelgen Biopharma Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 145. Gelgen Biopharma Product
Table 146. Gelgen Biopharma Recent Development
Table 147. Sandoz Corporation Information
Table 148. Sandoz Description and Major Businesses
Table 149. Sandoz Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 150. Sandoz Product
Table 151. Sandoz Recent Development
Table 152. Teva Corporation Information
Table 153. Teva Description and Major Businesses
Table 154. Teva Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 155. Teva Product
Table 156. Teva Recent Development
Table 157. Hospira Corporation Information
Table 158. Hospira Description and Major Businesses
Table 159. Hospira Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 160. Hospira Product
Table 161. Hospira Recent Development
Table 162. Mylan Corporation Information
Table 163. Mylan Description and Major Businesses
Table 164. Mylan Biologics & Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 165. Mylan Product
Table 166. Mylan Recent Development
Table 167. Global Biologics & Biosimilars Sales Forecast by Regions (2021-2026) (K Units)
Table 168. Global Biologics & Biosimilars Sales Market Share Forecast by Regions (2021-2026)
Table 169. Global Biologics & Biosimilars Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 170. Global Biologics & Biosimilars Revenue Market Share Forecast by Regions (2021-2026)
Table 171. North America: Biologics & Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 172. North America: Biologics & Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Europe: Biologics & Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 174. Europe: Biologics & Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Asia Pacific: Biologics & Biosimilars Sales Forecast by Region (2021-2026) (K Units)
Table 176. Asia Pacific: Biologics & Biosimilars Revenue Forecast by Region (2021-2026) (US$ Million)
Table 177. Latin America: Biologics & Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 178. Latin America: Biologics & Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 179. Middle East and Africa: Biologics & Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 180. Middle East and Africa: Biologics & Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 182. Key Challenges
Table 183. Market Risks
Table 184. Main Points Interviewed from Key Biologics & Biosimilars Players
Table 185. Biologics & Biosimilars Customers List
Table 186. Biologics & Biosimilars Distributors List
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics & Biosimilars Product Picture
Figure 2. Global Biologics & Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Antibiotic Product Picture
Figure 4. Enzyme Product Picture
Figure 5. Hormone Product Picture
Figure 6. Non-Patented Biological Reagents Product Picture
Figure 7. Other Product Picture
Figure 8. Global Biologics & Biosimilars Sales Market Share by Application in 2020 & 2026
Figure 9. Tumor
Figure 10. Diabetes
Figure 11. Cardiovascular
Figure 12. Hemophilia
Figure 13. Other
Figure 14. Biologics & Biosimilars Report Years Considered
Figure 15. Global Biologics & Biosimilars Market Size 2015-2026 (US$ Million)
Figure 16. Global Biologics & Biosimilars Sales 2015-2026 (K Units)
Figure 17. Global Biologics & Biosimilars Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Biologics & Biosimilars Sales Market Share by Region (2015-2020)
Figure 19. Global Biologics & Biosimilars Sales Market Share by Region in 2019
Figure 20. Global Biologics & Biosimilars Revenue Market Share by Region (2015-2020)
Figure 21. Global Biologics & Biosimilars Revenue Market Share by Region in 2019
Figure 22. Global Biologics & Biosimilars Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Biologics & Biosimilars Revenue in 2019
Figure 24. Biologics & Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Biologics & Biosimilars Sales Market Share by Type (2015-2020)
Figure 26. Global Biologics & Biosimilars Sales Market Share by Type in 2019
Figure 27. Global Biologics & Biosimilars Revenue Market Share by Type (2015-2020)
Figure 28. Global Biologics & Biosimilars Revenue Market Share by Type in 2019
Figure 29. Global Biologics & Biosimilars Market Share by Price Range (2015-2020)
Figure 30. Global Biologics & Biosimilars Sales Market Share by Application (2015-2020)
Figure 31. Global Biologics & Biosimilars Sales Market Share by Application in 2019
Figure 32. Global Biologics & Biosimilars Revenue Market Share by Application (2015-2020)
Figure 33. Global Biologics & Biosimilars Revenue Market Share by Application in 2019
Figure 34. North America Biologics & Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Biologics & Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Biologics & Biosimilars Sales Market Share by Country in 2019
Figure 37. North America Biologics & Biosimilars Revenue Market Share by Country in 2019
Figure 38. U.S. Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Biologics & Biosimilars Market Share by Type in 2019
Figure 43. North America Biologics & Biosimilars Market Share by Application in 2019
Figure 44. Europe Biologics & Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Biologics & Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Biologics & Biosimilars Sales Market Share by Country in 2019
Figure 47. Europe Biologics & Biosimilars Revenue Market Share by Country in 2019
Figure 48. Germany Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Biologics & Biosimilars Market Share by Type in 2019
Figure 59. Europe Biologics & Biosimilars Market Share by Application in 2019
Figure 60. Asia Pacific Biologics & Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Biologics & Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Biologics & Biosimilars Sales Market Share by Region in 2019
Figure 63. Asia Pacific Biologics & Biosimilars Revenue Market Share by Region in 2019
Figure 64. China Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Biologics & Biosimilars Market Share by Type in 2019
Figure 87. Asia Pacific Biologics & Biosimilars Market Share by Application in 2019
Figure 88. Latin America Biologics & Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Biologics & Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Biologics & Biosimilars Sales Market Share by Country in 2019
Figure 91. Latin America Biologics & Biosimilars Revenue Market Share by Country in 2019
Figure 92. Mexico Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Biologics & Biosimilars Market Share by Type in 2019
Figure 99. Latin America Biologics & Biosimilars Market Share by Application in 2019
Figure 100. Middle East and Africa Biologics & Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Biologics & Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Biologics & Biosimilars Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Biologics & Biosimilars Revenue Market Share by Country in 2019
Figure 104. Turkey Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Biologics & Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Biologics & Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Biologics & Biosimilars Market Share by Type in 2019
Figure 111. Middle East and Africa Biologics & Biosimilars Market Share by Application in 2019
Figure 112. North America Biologics & Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Biologics & Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Biologics & Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Biologics & Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Biologics & Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Biologics & Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Biologics & Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Biologics & Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Biologics & Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Biologics & Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- G-CSF・G-CSFバイオシミラーの世界市場（～2026年） G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimu…
- G-CSFバイオシミラーの世界市場（～2026年） Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are…
- HGHバイオシミラーの世界市場（～2026年） HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection…